Free Papers

Evaluation of postoperative visual acuity outcomes and long-term complications of toxic anterior segment syndrome after uneventful cataract surgery

Free Paper Details

First Author: R.Garip TURKEY

Co Author(s):    K. Sakallıoğlu   S. Kaya                 

Abstract Details

Purpose:

The aim of this study was to evaluate the early clinical presentation, treatment responses, visual acuity outcomes, and long-term complications in patients with toxic anterior segment syndrome (TASS) developing after uncomplicated cataract surgery.

Setting:

Trakya University School of Medicine, Department of Ophthalmology

Methods:

This retrospective, comparative case series was conducted with 60 eyes of 60 patients diagnosed with TASS after uncomplicated cataract surgery. The control group consisted of 58 eyes of 58 randomly selected patients who underwent uncomplicated cataract surgery in the same period. All patients underwent a complete ophthalmologic examination at each visit. Best-corrected visual acuity (BCVA) was evaluated at postoperative 1st day, 1st week, 1st month, 3rd month, and 6th month. The change in BCVA of study group were analyzed and compared with the control group. The postoperative anterior and posterior segment findings that could be attributed to TASS were evaluated.

Results:

In both groups, there was a significant increase in BCVA in the first month ( p˂0.001). On the postoperative 1st day, the mean BCVA of the study group was significantly lower than the control group (p˂0.001). Complications were evaluated in 53 eyes. Posterior capsule opacification (PCO) developed in 16 eyes (30.2%) in the study group and 8 eyes (13.8%) in the control group (p=0.036). Cystoid macular edema developed in 1 eye (1.7%) in the study group and in 4 eyes (6.9%) in the control group (p=0.159). None of the patients had developed permanent corneal edema or glaucoma.

Conclusions:

The final BCVA after treatment was better than at the onset of inflammation and similar to that of the control group which had no sign of ocular inflammation. Thus, the visual prognosis of all patients remained good. No vision-threatening complications were observed.

Financial Disclosure:

-